Oncology Review (NCCN Guidelines)

Select from the various topics below and click on the link to get an inside view of how our P&T committee responded to the issue. 

Pharma Support for NCCN

Oncologist Opinion of NCCN

UHC Adoption of NCCN

Payer Opinion of Oncologists Overuse of Drugs

Decrease in PA Costs

Vectibix and Erbitux Reduction and Use

Diagnostic Testing

Plan Options

 

top of page